Cooperative role for activated alpha 4 beta 1 integrin and chondroitin sulfate proteoglycans in cell adhesion to the heparin III domain of fibronectin - Identification of a novel heparin and cell binding sequence in repeat III5
Jv. Moyano et al., Cooperative role for activated alpha 4 beta 1 integrin and chondroitin sulfate proteoglycans in cell adhesion to the heparin III domain of fibronectin - Identification of a novel heparin and cell binding sequence in repeat III5, J BIOL CHEM, 274(1), 1999, pp. 135-142
We recently reported that the heparin (Hep) III domain of fibronectin conta
ins the H2 cell adhesion site in repeat III5 which binds activated alpha 4
integrins, We have now further characterized the heparin and cell binding a
ctivities of this domain. A recombinant fragment containing repeats III4-II
I5 (FN-III4-5) induced Jurkat cell adhesion upon integrin activation with M
n2+ or TS2/16 monoclonal antibody (anti-beta 1). Adhesion of Mn2+ treated c
ells to FN-III4-5 or FN-IIIB fragments was inhibited by chondroitinase ABC
and ACII but not by the anti-alpha 4 monoclonal antibody HP2/1, In contrast
, HP2/1 completely blocked adhesion of TS2/16-treated cells while chondroit
inase had a partial (FN-III4-5) or minor (FN-III5) effect. Thus, the role o
f each receptor depended on the stimulus used to activate alpha 4 beta 1, T
he combination of HP2/1 and chondroitinase at dilutions which did not inhib
it when used individually abolished adhesion of Mn2+ or TS2/16-treated cell
s to both fragments, indicating a cooperative effect between alpha 4 beta 1
and chondroitin sulfate proteoglycans (CSPG). Furthermore, we have identif
ied a 20-amino acid sequence in III5 (HBP/III5) which binds heparin and ind
uces cell adhesion via CSPG exclusively. Although soluble HBP/III5 was a po
or inhibitor, when combined with H2, it abolished adhesion to FN-III4-5 and
FN-III5 fragments. These results establish that adhesion to the Rep III do
main involves the cooperation of activated alpha 4 beta 1 and CSPG and show
that HBP/III5 is a novel heparin and CSPG-binding site contributing to cel
l adhesion to this domain.